Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Tired of being spoon-fed the algorithm and want to bypass the chaos of social feeds? Kadaza homepage puts you back in the ...
Eli Lilly (LLY) rated Sell/Avoid: overvaluation, slowing GLP-1 growth, Novo competition, bearish technicals and insider ...
BofA Securities 2026 Information & Business Services Conference March 12, 2026 2:15 PM EDTCompany ParticipantsAdam ...
Pure is a hookup app for anonymous casual encounters. It's designed to get you laid quickly and discreetly, with no strings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results